Table of Content

Open Access iconOpen Access

ARTICLE

Tamsulosin to treat uncomplicated distal ureteral calculi: a double blind randomized placebo-controlled trial

Taha A. Abdel-Meguid1,2, Abdulmalik Tayib1, Ahmad Al-Sayyad1

1 Department of Urology, King Abdulaziz University Medical City, Jeddah, Saudi Arabia
2 Department of Urology, El-Minia University, El-Minia, Egypt
Address correspondence to Dr. Taha Abo-Almagd Abdel-Meguid, Department of Urology, King Abdulaziz University Hospital, P.O. Box 80215, Jeddah, 21589, Saudi Arabia

Canadian Journal of Urology 2010, 17(3), 5178-5183.

Abstract

Purpose: To evaluate efficacy and outcome of tamsulosin therapy for 4 mm-10 mm uncomplicated distal ureteral stones.
Materials and methods: A total of 150 patients (adults with newly diagnosed single unilateral distal ureteral 4 mm-10 mm stones) were double blindly randomized into GA or GB. All patients received traditional treatment of hydration and analgesia as needed. Additionally, patients received either placebo (GA) or 0.4 mg tamsulosin (GB) oral tablets once daily. Treatment and follow up were continued for up to 4 weeks. Endpoints were spontaneous stone passage rates (SPR) and passage time for different stone sizes within 4 weeks study period.
Results: Analysis included 75 patients, in each group, with comparable characteristics. Overall SPR was 56% in GA and 81.3% in GB; achieving significant absolute risk reduction (ARR = 25.3%; p < 0.01) and number needed to treat (NNT) of 3.95. SPR for stones ≤ 6 mm was 69.2% in GA versus 90.7% in GB (ARR = 21.5%, p < 0.01). For stones 7 mm-10 mm, SPR was 26.1% in GA and 57.1% in GB (ARR = 31.0%, p < 0.01). NNT for ≤ 6 mm and 7 mm-10 mm stones was 4.65 and 3.23, respectively (p < 0.05). Median time for passage of ≤ 6 mm stones was 17 versus 9 days in GA and GB; while for 7 mm-10 mm stones it was 20 versus 15 days, respectively. During the first two weeks, 77.8% of ≤ 6 mm stones in GB have passed versus 23.8% of 7 mm-10 mm stones. Analgesia consumption was significantly less in GB (p < 0.01). No significant adverse effects were observed.
Conclusions: Tamsulosin therapy for uncomplicated distal ureteral calculi augments SPR, shortens passage time and decrease need for analgesia. Particularly, tamsulosin shortens the passage time for smaller stones, and augments the passage rate for larger stones.

Keywords

ureter, adrenergic alpha-antagonists, tamsulosin, urinary calculi

Cite This Article

APA Style
Abdel-Meguid, T.A., Tayib, A., Al-Sayyad, A. (2010). Tamsulosin to treat uncomplicated distal ureteral calculi: a double blind randomized placebo-controlled trial. Canadian Journal of Urology, 17(3), 5178–5183.
Vancouver Style
Abdel-Meguid TA, Tayib A, Al-Sayyad A. Tamsulosin to treat uncomplicated distal ureteral calculi: a double blind randomized placebo-controlled trial. Can J Urology. 2010;17(3):5178–5183.
IEEE Style
T.A. Abdel-Meguid, A. Tayib, and A. Al-Sayyad, “Tamsulosin to treat uncomplicated distal ureteral calculi: a double blind randomized placebo-controlled trial,” Can. J. Urology, vol. 17, no. 3, pp. 5178–5183, 2010.



cc Copyright © 2010 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 149

    View

  • 107

    Download

  • 0

    Like

Share Link